MedTrace Logo

Feasibility Study of Finesse for Bolus Prandial Insulin Dosing Compared to Multiple Daily Injections

NCT01073566 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2025-02-04

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate that Finesse, for prandial insulin bolusing when used in conjunction with basal insulin, achieves equivalent glycemic control when compared to multiple daily injections and to evaluate its preference.

Conditions

Interventions

DEVICE

Finesse

Finesse Insulin Delivery Patch

DEVICE

Pen/Syringe (Usual injection device)

Pen/Syringe

Sponsors & Collaborators

  • Nancy Bohannon, MD, Med. Corp.

    collaborator UNKNOWN

  • Henry Ford Health System

    collaborator OTHER

  • Northwestern University

    collaborator OTHER

  • University of Texas Southwestern Medical Center

    collaborator OTHER

  • International Diabetes Center at Park Nicollet

    collaborator OTHER

  • Calibra Medical, Inc.

    lead INDUSTRY

Principal Investigators

  • Vice President Clinical Affairs · Calibra Medical, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2010-07-31
Completion
2010-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01073566 on ClinicalTrials.gov